Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.

IF 2.5 4区 医学 Q3 ONCOLOGY
Najla A Lakkis, Reem M Abdallah, Umayya M Musharrafieh, Hanane G Issa, Mona H Osman
{"title":"Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.","authors":"Najla A Lakkis, Reem M Abdallah, Umayya M Musharrafieh, Hanane G Issa, Mona H Osman","doi":"10.1177/10732748241236266","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study explores the incidence and trends of breast (Bca), corpus uteri (CUca), and ovarian (Oca) cancer in Lebanon, a Middle Eastern country. It compares the Bca rates to regional and global ones and discusses Bca risk factors in Lebanon.</p><p><strong>Introduction: </strong>Globally, Bca is the premier cause of cancer morbidity and mortality in women.</p><p><strong>Methods: </strong>Data on female Bca, CUca, and Oca published by the Lebanese national cancer registry were obtained (ie, for the years of 2005 to 2016). The age-standardized incidence rates (ASIRw) and age-specific rates per 100,000 female population were computed.</p><p><strong>Results: </strong>From 2005 to 2016, Bca, Oca, and CUca ranked first, sixth, and seventh, respectively, for cancer incidence among women in Lebanon. Bca alone accounted for 39.4% of all new female cancer cases. The ASIRw increased significantly for Bca and CUca (APC: 3.60 and 3.73, <i>P</i> < .05) but not for Oca (APC: 1.27, <i>P</i> > .05). The Bca ASIRw (per 100,000) increased significantly from 71.0 in 2005 to 115.6 in 2013 (<i>P</i> < .05), then decreased steadily but non-significantly to reach 96.8 in 2016 (<i>P</i> > .05). Lebanon's Bca ASIRw is comparable to developed countries. This may reflect altered sociological and reproductive patterns as the country transitions from regional to global trends. The five-year age-specific rates analysis revealed that Bca rates rose steeply from 35-39 to 50-54, dropped slightly between 55 and 64, then rose till 75+. The five-year age-specific rates between 35 and 54 among Lebanese women were amongst the highest worldwide from 2008 to 2012, even higher than the rates in Belgium, which had the highest ASIRw of Bca worldwide in 2020.</p><p><strong>Conclusion: </strong>Lebanon's Bca ASIRw is among the highest globally. It's important to investigate the contributing factors and develop a national Bca control strategy. This study supports the national recommendation in initiating Bca screening at age 40 for women.</p>","PeriodicalId":49093,"journal":{"name":"Cancer Control","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10903209/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10732748241236266","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study explores the incidence and trends of breast (Bca), corpus uteri (CUca), and ovarian (Oca) cancer in Lebanon, a Middle Eastern country. It compares the Bca rates to regional and global ones and discusses Bca risk factors in Lebanon.

Introduction: Globally, Bca is the premier cause of cancer morbidity and mortality in women.

Methods: Data on female Bca, CUca, and Oca published by the Lebanese national cancer registry were obtained (ie, for the years of 2005 to 2016). The age-standardized incidence rates (ASIRw) and age-specific rates per 100,000 female population were computed.

Results: From 2005 to 2016, Bca, Oca, and CUca ranked first, sixth, and seventh, respectively, for cancer incidence among women in Lebanon. Bca alone accounted for 39.4% of all new female cancer cases. The ASIRw increased significantly for Bca and CUca (APC: 3.60 and 3.73, P < .05) but not for Oca (APC: 1.27, P > .05). The Bca ASIRw (per 100,000) increased significantly from 71.0 in 2005 to 115.6 in 2013 (P < .05), then decreased steadily but non-significantly to reach 96.8 in 2016 (P > .05). Lebanon's Bca ASIRw is comparable to developed countries. This may reflect altered sociological and reproductive patterns as the country transitions from regional to global trends. The five-year age-specific rates analysis revealed that Bca rates rose steeply from 35-39 to 50-54, dropped slightly between 55 and 64, then rose till 75+. The five-year age-specific rates between 35 and 54 among Lebanese women were amongst the highest worldwide from 2008 to 2012, even higher than the rates in Belgium, which had the highest ASIRw of Bca worldwide in 2020.

Conclusion: Lebanon's Bca ASIRw is among the highest globally. It's important to investigate the contributing factors and develop a national Bca control strategy. This study supports the national recommendation in initiating Bca screening at age 40 for women.

黎巴嫩乳腺癌、子宫体癌和卵巢癌的流行病学,重点是乳腺癌发病趋势和风险因素与地区和全球发病率的比较。
研究目的本研究探讨了中东国家黎巴嫩的乳腺癌(Bca)、子宫癌(CUca)和卵巢癌(Oca)的发病率和趋势。该研究将黎巴嫩的乳腺癌发病率与地区和全球的乳腺癌发病率进行了比较,并讨论了黎巴嫩的乳腺癌风险因素:在全球范围内,白血病是女性癌症发病率和死亡率的首要原因:方法:获取黎巴嫩国家癌症登记处公布的女性Bca、CUca和Oca数据(即2005年至2016年的数据)。结果:2005 年至 2016 年,每 10 万名女性人口中,Bca、CUca 和 Oca 的年龄标准化发病率(ASIRw)和年龄特异性发病率均有所下降:从 2005 年到 2016 年,Bca、Oca 和 CUca 在黎巴嫩女性癌症发病率中分别排名第一、第六和第七。在所有女性癌症新病例中,仅Bca就占了39.4%。Bca和CUca的ASIRw明显增加(APC:3.60和3.73,P < .05),而Oca则没有增加(APC:1.27,P > .05)。Bca ASIRw(每 100,000 人)从 2005 年的 71.0 显著上升至 2013 年的 115.6(P < .05),随后稳步下降,但降幅不大,2016 年为 96.8(P > .05)。黎巴嫩的Bca ASIRw与发达国家相当。这可能反映了随着该国从地区趋势向全球趋势过渡,社会和生育模式发生了变化。五年特定年龄比率分析表明,Bca 比率在 35-39 岁至 50-54 岁期间急剧上升,在 55-64 岁期间略有下降,然后一直上升到 75 岁以上。从 2008 年到 2012 年,黎巴嫩妇女在 35 岁到 54 岁之间的五年年龄特定比率是全球最高的,甚至高于比利时的比率:黎巴嫩的Bca ASIRw属于全球最高之列。结论:黎巴嫩的乙型肝炎 ASIRw 是全球最高的之一,调查其诱因并制定国家乙型肝炎控制策略非常重要。这项研究支持国家关于女性在 40 岁时开始进行 Bca 筛查的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Control
Cancer Control ONCOLOGY-
CiteScore
3.80
自引率
0.00%
发文量
148
审稿时长
>12 weeks
期刊介绍: Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信